<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000045396"><TermName>PSC 833</TermName><TermDefinition><DefinitionText>A substance that is being studied for its ability to prevent or overcome the resistance of tumor cells to some anticancer drugs. It belongs to the family of drugs called cyclosporine analogs.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><SpanishTermName>PSC 833</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio por su capacidad de prevenir o superar la resistencia de las células tumorales a algunos medicamentos contra el cáncer. Es un tipo de análogo de la ciclosporina.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateLastModified>2005-03-02</DateLastModified></GlossaryTerm>
